LBT Innovations Limited (LBT.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -604 Thousand AUD | -38.11% |
| 2023 | 1.36 Million AUD | -8.81% |
| 2022 | 1.49 Million AUD | 131.51% |
| 2021 | -4.75 Million AUD | -47.6% |
| 2020 | -3.22 Million AUD | 58.01% |
| 2019 | -7.67 Million AUD | -1.36% |
| 2018 | -7.57 Million AUD | -116.47% |
| 2017 | -3.49 Million AUD | 25.29% |
| 2016 | -4.68 Million AUD | -512.83% |
| 2015 | -764 Thousand AUD | 57.34% |
| 2014 | -1.79 Million AUD | -104.45% |
| 2013 | -876 Thousand AUD | 70.12% |
| 2012 | -2.93 Million AUD | 11.69% |
| 2011 | -3.32 Million AUD | 34.39% |
| 2010 | -5.06 Million AUD | -57.44% |
| 2009 | -3.21 Million AUD | 18.47% |
| 2008 | -3.94 Million AUD | 56.03% |
| 2007 | -8.96 Million AUD | 0.0% |
| 2005 | -4.17 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | 846 Thousand AUD | -38.11% |
| 2024 Q4 | -604 Thousand AUD | 0.0% |
| 2024 Q2 | 50 Thousand AUD | 0.0% |
| 2023 Q2 | 227 Thousand AUD | 0.0% |
| 2023 FY | 1.36 Million AUD | -8.81% |
| 2023 Q4 | 1.36 Million AUD | 0.0% |
| 2022 Q4 | 1.49 Million AUD | 0.0% |
| 2022 FY | 1.49 Million AUD | 131.51% |
| 2022 Q2 | -2.5 Million AUD | 0.0% |
| 2021 Q4 | -4.75 Million AUD | 0.0% |
| 2021 FY | -4.75 Million AUD | -47.6% |
| 2021 Q2 | -9.54 Million AUD | 0.0% |
| 2020 Q4 | -3.22 Million AUD | 0.0% |
| 2020 FY | -3.22 Million AUD | 58.01% |
| 2020 Q2 | -5.79 Million AUD | 0.0% |
| 2019 FY | -7.67 Million AUD | -1.36% |
| 2019 Q2 | -5.71 Million AUD | 0.0% |
| 2019 Q4 | -7.67 Million AUD | 0.0% |
| 2018 Q4 | -7.57 Million AUD | 0.0% |
| 2018 Q2 | -4.23 Million AUD | 0.0% |
| 2018 FY | -7.57 Million AUD | -116.47% |
| 2017 Q2 | -5.27 Million AUD | 0.0% |
| 2017 FY | -3.49 Million AUD | 25.29% |
| 2017 Q4 | -3.49 Million AUD | 0.0% |
| 2016 Q4 | -4.68 Million AUD | 0.0% |
| 2016 Q2 | -6.67 Million AUD | 0.0% |
| 2016 FY | -4.68 Million AUD | -512.83% |
| 2015 Q4 | -764 Thousand AUD | 0.0% |
| 2015 FY | -764 Thousand AUD | 57.34% |
| 2015 Q2 | -1.54 Million AUD | 0.0% |
| 2014 Q2 | -2.08 Million AUD | 0.0% |
| 2014 FY | -1.79 Million AUD | -104.45% |
| 2014 Q4 | -1.79 Million AUD | 0.0% |
| 2013 Q2 | -2.42 Million AUD | 0.0% |
| 2013 Q4 | -876 Thousand AUD | 0.0% |
| 2013 FY | -876 Thousand AUD | 70.12% |
| 2012 FY | -2.93 Million AUD | 11.69% |
| 2012 Q4 | -2.93 Million AUD | 0.0% |
| 2011 FY | -3.32 Million AUD | 34.39% |
| 2011 Q4 | -3.32 Million AUD | 0.0% |
| 2010 Q4 | -5.06 Million AUD | 0.0% |
| 2010 FY | -5.06 Million AUD | -57.44% |
| 2009 FY | -3.21 Million AUD | 18.47% |
| 2009 Q4 | -3.21 Million AUD | 0.0% |
| 2008 FY | -3.94 Million AUD | 56.03% |
| 2008 Q4 | -3.94 Million AUD | 0.0% |
| 2007 FY | -8.96 Million AUD | 0.0% |
| 2007 Q4 | -8.96 Million AUD | 0.0% |
| 2005 FY | -4.17 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 97.63% |
| Adherium Limited | -6.1 Million AUD | 90.105% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 83.881% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 83.238% |
| Anteris Technologies Ltd | -28.49 Million AUD | 97.881% |
| Control Bionics Limited | -19.02 Thousand AUD | -3075.271% |
| CardieX Limited | 2.74 Million AUD | 121.993% |
| Compumedics Limited | 5.08 Million AUD | 111.873% |
| Cochlear Limited | -269.9 Million AUD | 99.776% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 186.46% |
| Cyclopharm Limited | -7.49 Million AUD | 91.946% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 96.153% |
| Nova Eye Medical Limited | -2.8 Million AUD | 78.444% |
| HeraMED Limited | -799.34 Thousand AUD | 24.438% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 104.17% |
| ImpediMed Limited | -23.48 Million AUD | 97.429% |
| InhaleRx Limited | -155.54 Thousand AUD | -288.315% |
| Micro-X Limited | 826.99 Thousand AUD | 173.035% |
| Neurotech International Limited | -2.11 Million AUD | 71.381% |
| OncoSil Medical Limited | -4.43 Million AUD | 86.368% |
| PolyNovo Limited | -30.52 Million AUD | 98.021% |
| Respiri Limited | 413.68 Thousand AUD | 246.003% |
| SomnoMed Limited | -15.16 Million AUD | 96.017% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 88.612% |
| Uscom Limited | -1.53 Million AUD | 60.539% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 85.207% |